
MenaQ7® and Quatrefolic® for elderly health applications were highlighted during a seminar organized by Gnosis and distributor, SAMOH Pharm. The seminar was held on 11 October and attracted more than 150 attendees from 70 companies.
Quatrefolic® and MenaQ7® are two powerful ingredients that can promote better health for the eldery and individuals concerned with bone and cardiovascular health.
Empowering Korean Seniors with MenaQ7® and Quatrefolic®: A Path to Enhanced Elderly Health
MenaQ7® and Quatrefolic® play a pivtoal role in enhancing the health of the elderly population in Korea.
MenaQ7®, a form of vitamin K2 as MK-7, supports bone and cardiovascular health, cruical for seniors.
Quatrefolic®, a bioavailable form of folate, aids in cognitive function and overall well-being.
These premium ingredients address nutritional needs, promoting vitality among the aging demographic in Korea.
Latest news & videos

- Corporate
- Digestion & Gut
- News
- Jun 06, 2025
Biotic Live: A Successful First Edition Exploring the Power of Probiotic Yeasts
Gnosis by Lesaffre recently hosted the first edition of Biotic Live, a unique event...

- Mobility & Joint
- MyCondro®
- News
- Jun 05, 2025
Redefining Joint Health: Gnosis by Lesaffre Showcases MyCondro™ at CMA Innovation Day
At the recent Innovation Day seminar hosted by Complementary Medicines Australia (CMA), Gnosis by...

- MenaQ7®
- Mobility & Joint
- News
- Jun 02, 2025
Supplementation with Menaquinone-7 (as MenaQ7®) Slows the Progression of Coronary Artery Calcification
The first results from the VitaK-CAC Trial, “Menaquinone-7 Slows Down Progression of Coronary Artery...